Search terms
Results 2131 - 2140 of 2161 - ordered by :
Pages: 1 ... 211 212 213 214 215 216 217

Coming up Antithrombotic Therapies: clinical challenges and future directions A joint Educational Training Programme of the ESC Working Group on Aorta & Peripheral Vascular Diseases and the ESC ...

Date : 01/06/2019

Pioneered in Canada in 2005 by interventional cardiologist Dr John Webb and his team at St. Paul’s Hospital in Vancouver, the TAVI procedure is minimally invasive and does not require major ...

Date : 27/08/2012

DESolve is a first-in-man trial, targeting single de-novo coronary artery lesions using a bio-resorbable biolimus-eluting scaffold polymer which completely dissolves over a ? year period. The study ...

Date : 17/05/2012

Professor Alec Vahanian (Department of Cardiology, Hôpital Bichat, University of Paris VI, Paris, France) says that the 20 different registries of the EURObservational Research Programme are ...

Date : 27/08/2017

[...]generation TAVI device - Lotus Valve - shows good performance in REPRISE II The Lotus Valve, a second-generation transcatheter aortic valve implantation (TAVI) device, was successfully implanted ...

Date : 23/05/2013

Embargoed 9 September 2016 at 07:00 CEST Cape Town, South Africa 9 September 2016: A novel heart valve replacement method is revealed today that offers hope for the thousands of patients with ...

Date : 09/09/2016

For a subset of patients in whom surgical conventional aortic valve replacement is excluded due to severe co-morbidities, an alternative to surgical aortic valve replacement ? transcatheter aortic ...

Date : 29/08/2011

An updated meta-analysis of seven RCTs comparing TAVI and SAVR among 8,020 patients with severe, symptomatic aortic stenosis reported a lower risk of all-cause mortality (12% relative risk reduction) ...

Date : 21/05/2019

TAVI, introduced in 2002 by Dr Alain Cribier from France and 2005 by Dr John Webb from Canada, has been shown to improve survival compared with standard therapy in patients with severe aortic ...

Date : 28/08/2012

There are around one million individuals in Portugal with more than 75 years of age and about 4.500 have indication to TAVI due to high risk or inoperability. [...]if indications are expanded to ...

Date : 29/05/2017